Nuropod has released a guide examining the vagus nerve’s role in lung function, airway control, and breathing patterns, including a look at how common breathing practices relate to actual vagus nerve stimulation.
-- Nuropod, the U.S. wellness brand behind a wearable vagus nerve stimulation device, has released an educational guide detailing how the vagus nerve influences the lungs, airways, and everyday breathing patterns.
More information is available at https://nuropod.com/blogs/articles/how-does-the-vagus-nerve-affect-the-lungs-breathing-nervous-system-functions
The release responds to growing public interest in the vagus nerve and its role in many bodily functions, including heart rate, digestion, and breathing. Nuropod’s guide narrows that focus to the lungs and airways and explains why signals between the lungs and brainstem matter for each breath.
The guide first outlines the vagus nerve’s function in the airways, covering resting airway tone, mucus clearance, and the cough reflex. It also describes the nerve’s supply to the muscles of the voice box and how this relates to coughing and throat clearing.
Readers will find a section on the nerve’s contribution to the rhythm of breathing, including the signaling between the lungs and the brainstem that helps bring each in-breath to a close. The section also explains heart rate variability (HRV), a measure of the variation in time between heartbeats, and outlines how breathing and heart rate are connected.
Further sections discuss how breathing patterns differ between fight-or-flight and rest-and-digest states and address whether slow breathing, humming, and gargling stimulate the vagus nerve. A frequently asked questions section covers topics such as which nerve controls breathing rate and where the vagus nerve runs through the neck and chest.
For readers seeking to support their nervous system alongside breathing practices, the guide also introduces Nuropod. The device’s earpiece clips onto the tragus, the part of the outer ear just in front of the ear canal, and delivers gentle electrical pulses through Parasym’s proprietary AVNT™ waveform to support the nervous system.
Nuropod requires no gel, prescription, or clinic visit, and most people use it for around 30 minutes, once or twice a day, while working, reading, or watching television. It has not been studied for direct effects on lung or airway function, and is used alongside existing care, not instead of it.
To read the complete guide or learn more about the device, visit https://nuropod.com
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89208974
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
